Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- N/A
Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
- Status
- RECRUITING
- Phase
- N/A
Fruquintinib in Refractory Metastatic Colorectal Cancer: A Real-world Study
- Status
- COMPLETED
- Phase
- N/A
Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
- Status
- RECRUITING
- Phase
- NA
Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Real-world Study of Trifluridine/Tipiracil Containing Regimen for the Treatment of Patients With mCRC (REFLECT Study)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype
- Status
- RECRUITING
- Phase
- NA
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment
- Status
- COMPLETED
- Phase
- N/A
Sulfasalazine in Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Crisaborole Ointment for Skin Toxicity Induced by Cetuximab
- Status
- RECRUITING
- Phase
- PHASE2
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Fruquintinib in the Cross-line Treatment of Refractory mCRC
- Status
- RECRUITING
- Phase
- N/A
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
- Status
- RECRUITING
- Phase
- PHASE1
Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.
- Status
- RECRUITING
- Phase
- PHASE2
Nitazoxanide in Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3